The global Equine Healthcare market is estimated to develop at a compound annual growth rate (CAGR) of 6.82%.
The global Equine Healthcare market is estimated to develop at a compound annual growth rate (CAGR) of 6.82%. The global Equine Healthcare market size was valued at USD 1.20 billion in 2021, and it is predicted to exceed USD 2.30 billion by 2030. The study investigates several elements and their consequences on the growth of the Equine Healthcare market.
Full Report is Ready | Request Sample of This Report @ https://www.novaoneadvisor.com/report/sample/6343
Horse breeding is a core activity in the equine industry. Hence, choice of breeding stock and better healthcare management of breeds are crucial to improve breeding operations. Occurrence of equine infections is another major concern for the breeders. For instance, South America and the Caribbean have high incidence of Potomac horse fever.
The West Nile Virus infection among horses have been controlled; however, sudden emergence of the virus can cause concerns among the horse owners. Moreover, tetanus and equine influenza cases are evident among the global horse community. Hence, high incidence of equine infections is projected to drive the global equine healthcare market.
Report Scope of the Equine Healthcare Market
| Report Coverage | Details |
| Market Size | US$ 2.30 Billion by 2030 |
| Growth Rate | CAGR of 6.82% from 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Drugs Segment to Dominate Market
Equine drugs was the largest segment in terms of revenue in 2020. The segment is anticipated to expand at a high CAGR during the forecast period. Equine drugs comprise a range of products, including anti-inflammatory, anti-infectives, and parasiticides that are used to manage reproductive, metabolic or cardiovascular conditions. Increase in pet ownership and overall expenditure on equine healthcare care have augmented the market for both prescription as well as over-the-counter (OTC) drugs.
Full Report is Ready |Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/6343
Veterinary Hospitals/Clinics to be Major Distribution Channel
In terms of distribution channel, the veterinary hospitals & clinics segment accounted for major share of the global equine healthcare market in 2020. The veterinary hospitals & clinics segment is anticipated to capture the largest market share by 2028. The segment is projected to register high market attractiveness during the forecast period. The availability of a range of equine healthcare products such as drugs, vaccines, and nutritional supplements in veterinary hospitals and clinics and authenticity of products are attributed to the segment’s major market share. The recent trend of surveillance activities from the international and regional animal healthcare agencies is another factor that drives the segment.
North America to Lead Global Market
North America accounted for a significant share of the global equine healthcare market in 2020, followed by Europe. These two regions are projected to be highly lucrative markets during the forecast period. High adoption rate of horses per household, impressive animal healthcare expenditure, influence of animal welfare program, strong animal research infrastructure, and presence of key vendors can be attributed to high market share of the two regions.
Some of the prominent players in the Equine Healthcare market include:
- Bayer AG (Bayer Animal healthcare)
- BoehringerIngelheim
- Ceva Santé Animale
- Eli Lilly and Company (Elanco)
- Equine Products UK Ltd.
- Merck & Co. (Merck Animal healthcare)
- Sanofi (Merial)
- Purina Animal Nutrition LLC.
- Vetoquinol S.A.
- Zoetis
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
Global Equine Healthcare Market: Segmentation
Equine Healthcare Market, by Product Type
- Drugs
- Anti-infectives
- Anti-inflammatory
- Parasititidis
- Others
- Vaccines
- Inactivated
- Live Attenuated
- Recombinant
- Others
- Medical Supplemental Feed
- Minerals
- Vitamins
- Protein
- Enzyme
- Others
Equine Healthcare Market, by Disease Type
- West Nile Virus
- Equine Rabies
- Potomac Horse Fever
- Tetanus
- Equine Influenza
- Equine Herpes Virus
- Equine Encephalomyelitis
- Others (Equine Infectious Anemia)
Equine Healthcare Market, by Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Pharmacies & Drug Stores
- Others
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Click Here to View Full Report Table of Contents
Key Questions Answered in Equine Healthcare Market Report
What will be the sales/revenue generated by Equine Healthcare across all regions during the forecast period?
What are the opportunities in the global Equine Healthcare market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which application is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market position of different companies operating in the global market?
Full Report is Ready |Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/6343
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
About Us
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. We endeavor to give our clients latest insights on upcoming technologies, new developing markets, dynamically changing business conditions and most recent business-driven applications. These insights help our clients to take informed decisions for their business growth. We for the most part center around supporting our clients with aggressive insight, helping them to anchor an upper hand in the market and achieve reasonable development in various market spaces. Capable with an exceedingly skilled, experienced and to a great degree qualified group of specialists including SMEs, investigators and advisors, we attempt to provide value-added business solutions to our customers. Through dedicated subjective and quantitative market research techniques and supporting consulting assignments, we adeptly formulate competitive strategies to address business challenges for our customers through investigating market drifts, trends and rising advances in emerging technologies.
For Latest Update Follow Us:
https://www.linkedin.com/company/nova-one-advisor
https://twitter.com/NovaOneAdvisor
https://www.facebook.com/Nova-One-Advisor-116142276949837/